Navigation Links
CIAs in Medical News

When CIAs Poisoned Capsule for Castro Stuck to the Freezer!

That the notorious US Central Intelligence Agency mounted innumerable attempts to kill its bete noire, Cubas Fidel Castro, is well known . Forget the politics of it all, the CIA has indeed been resourceful, even if they came to grief every time. Castro has already turned 80. Still the recen...

A Drug That Receives Regulatory Approval for Cognitive Impairment Associated With Schizophrenia Would Earn a Higher Patient Share in the United States Than in Europe

... CIAS. To date, no drugs are formally approved for cias and off-label treatment is sporadic. However, clin...and Merck could demonstrate advantages in treating cias when compared with donepezil (Eisai/Pfizer's Arice...en benefits in other indications in the hopes that cias patients will experience similar benefits," said D...

Memory Pharmaceuticals Closes Second Tranche of Equity Financing with The Stanley Medical Research Institute

...tional milestone related to the Phase 2a trial of MEM 3454 in CIAS. "We are extremely pleased with the progress of our Phase 2a trial of MEM 3454 in cias and that we have been able to translate our achievements into an opportunity to raise additional capital at favorable terms," stated Vaughn M. Kailian...

Memory Pharmaceuticals Announces Positive Phase 2a Results for MEM 3454 in Alzheimer's Disease

...ated with schizophrenia. The expanded agreement provides that Roche would have to make an additional milestone payment upon completion of the Phase 2a cias trial in order to maintain its license to MEM 3454. Under this agreement, Memory Pharmaceuticals and Roche actively collaborate on the discovery and ...
CIAs in Medical Technology

Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia

...87/MEM 3454 or placebo once daily for a period of eight weeks. The primary objective of the trial is to assess the effectiveness of R3487/MEM 3454 in cias using the MATRICS Consensus Cognitive Battery (MCCB). Secondary objectives include assessing the effectiveness of the drug to improve other symptoms o...

Memory Pharmaceuticals and Roche Expand R3487/MEM 3454 Development Program

...ment associated with the completion of the Phase 2 cias trial as follows: $3.5 million in connection with ... million upon the completion of enrollment for the cias trial. The payment of the remaining $8.5 million w...the availability of top-line data from the Phase 2 cias trial, which is now expected in the second quarter...

Memory Pharmaceuticals & Roche Expand Development Program for MEM 3454 in Schizophrenia

.... To maintain its license to MEM 3454, Roche would have to make an additional milestone payment to the Company upon completion of the ongoing Phase 2a cias trial, which is expected to be completed in the fourth quarter of 2008. Evoked Potentials in Schizophrenia Electrophysiology measures have long be...

TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia

...plans to initiate a Phase II dose-ranging trial in cias during the first half of 2008. A secondary object...ned timing of the initiating of clinical trials in cias and xerostomia. Such statements are subject to num...ee that NGX267 will successfully treat symptoms of cias or xerostomia, the dose range may not be effective...
CIAs in Biological Technology

Memory Pharmaceuticals Reports Third Quarter 2008 Financial Results

...he. During the quarter, we also achieved a milestone related to the Phase 2 cias trial under our equity financing agreement with SMRI, triggering an additio...me due 30 days following the availability of top-line data from the Phase 2 cias trial. In addition, Roche has agreed to fund all internal and external cost...

Memory Pharmaceuticals Initiates Phase 2a Trial of MEM 3454 in Cognitive Impairment Associated with Schizophrenia

...rial is to assess the effectiveness of MEM 3454 in cias using the MATRICS Consensus Cognitive Battery (MCC... milestone payment upon completion of the Phase 2a cias trial to maintain its license to MEM 3454. The add...cted to cover the expenses related to the Phase 2a cias trial of MEM 3454. MEM 3454 is a partial agonist...
Other Tags
(Date:7/25/2014)... UK (PRWEB) July 26, 2014 Dental ... variety of dental services including general dentistry, clear braces ... opening in September this year in Derby. The new ... at the HollyBrook Medical Centre in Littleover, Derby. Patients ... new practice. , The new dental practice, which is ...
(Date:7/25/2014)... July 26, 2014 2014 ... Gel Permeation Chromatography Industryā€¯ is a professional ... and China Gel Permeation Chromatography market. The ... including Gel Permeation Chromatography definition, classification, application, ... industry overview. This research covers the international ...
(Date:7/25/2014)... In recent years, men have become more aware of, ... associated with age-related testosterone decline. Amid concerns about testosterone and ... case study from Renew Man helps to shed light ... bioidentical hormones. , The case study centers around a patient ... beginning to feel the effects of age-related hormonal decline. ...
(Date:7/25/2014)... American motor vehicle owners who are at higher ... premiums for vehicle insurance on average. The Quotes Pros ... SR22 insurance for high risk motorists this year at ... of local agencies providing direct price quotations for risk ... available for any car owner to access. One advantage ...
(Date:7/25/2014)... As reported by the Statesman Journal in the article ... in Salem, MA as well as several other states are ... that has taken many lives during the past couple of ... which police were able to make two arrests by following ... be the victim and claiming to want to buy more ...
Breaking Medicine News(10 mins):Health News:Derby Cosmetic Dentist Dental Perfection to Open New Practice in Littleover, Derby this September 2Health News:2014 China & Global GPC Industry - Gel Permeation Chromatography Development Trends Now at DeepResearchReports.com 2Health News:2014 China & Global GPC Industry - Gel Permeation Chromatography Development Trends Now at DeepResearchReports.com 3Health News:New Case Study Highlights Effectiveness of Testosterone Therapy in Fighting Weight Gain and Fatigue 2Health News:New Case Study Highlights Effectiveness of Testosterone Therapy in Fighting Weight Gain and Fatigue 3Health News:SR22 Insurance for High Risk Motorists Added to Local Quotes System at Insurer Website Online 2Health News:Multiple States Crack Down on Heroin Epidemic 2
(Date:7/25/2014)... engineering at the University of Houston, has written ... organ development., "Introduction to Tissue Engineering: Applications and ... the field of artificial organ development. Metin Akay, ... UH, served as a series editor on the ... published books on the subject of growing artificial ...
(Date:7/25/2014)... (NRG1) is a pleiotropic factor characterized by the ... of exons that confer to the protein deeply ... both the myelination occurring during development and the ... nerve: axon degeneration, axon regrowth, remyelination and target ... have discovered that the soluble NRG1 upregulation observed ...
(Date:7/25/2014)... that the age girls reach puberty is influenced by ,imprinted ... parent contributes the gene. This is the first evidence ... birth and details of this study were published today in ... period, known as menarche, is a marker for the timing ... onset of menses varies between girls, is an inherited trait, ...
Breaking Biology News(10 mins):University of Houston researcher publishes textbook on tissue engineering 2Could age of first period influence development of diseases in older women? 2
Other Contents